Horta M, Soares P, Leite Pereira C, Lima R
Pharmaceutics. 2025; 17(2).
PMID: 40006509
PMC: 11859630.
DOI: 10.3390/pharmaceutics17020142.
Dhiman A, Rana D, Benival D, Garkhal K
Ther Deliv. 2024; 16(1):87-115.
PMID: 39445563
PMC: 11703381.
DOI: 10.1080/20415990.2024.2415281.
Chen X, Wu D, Chen Z
MedComm (2020). 2024; 5(8):e643.
PMID: 39036340
PMC: 11260173.
DOI: 10.1002/mco2.643.
Barahuie F, Dorniani D, Saifullah B, Arulselvan P, Hussein M, Jaganathan R
Heliyon. 2024; 10(12):e32863.
PMID: 38994094
PMC: 11237972.
DOI: 10.1016/j.heliyon.2024.e32863.
Najjari Z, Sadri F, Varshosaz J
Asian J Pharm Sci. 2024; 18(6):100873.
PMID: 38173712
PMC: 10762358.
DOI: 10.1016/j.ajps.2023.100873.
A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil.
Akbar M, Khattak S, Khan M, Saddozai U, Ali N, Alasmari A
Front Pharmacol. 2023; 14:1265440.
PMID: 37745070
PMC: 10517339.
DOI: 10.3389/fphar.2023.1265440.
Unveiling the Structural Characteristics and Bioactivities of the Polysaccharides Extracted from Endophytic sp.
Vishven Naveen K, Sathiyaseelan A, Mandal S, Han K, Wang M
Molecules. 2023; 28(15).
PMID: 37570759
PMC: 10421393.
DOI: 10.3390/molecules28155788.
In Vitro Bioaccessibility Assessment of Phenolic Compounds from Encapsulated Grape Pomace Extract by Ionic Gelation.
Martinovic J, Lukinac J, Jukic M, Ambrus R, Planinic M, Selo G
Molecules. 2023; 28(13).
PMID: 37446946
PMC: 10343682.
DOI: 10.3390/molecules28135285.
Dual-Drug Delivery by Anisotropic and Uniform Hybrid Nanostructures: A Comparative Study of the Function and Substrate-Drug Interaction Properties.
Kargari Aghmiouni D, Khoee S
Pharmaceutics. 2023; 15(4).
PMID: 37111700
PMC: 10142803.
DOI: 10.3390/pharmaceutics15041214.
Enhancing the Antioxidant, Antibacterial, and Wound Healing Effects of Oil by Microencapsulating It in Chitosan-Sodium Alginate Microspheres.
Sathiyaseelan A, Zhang X, Wang M
Nutrients. 2023; 15(6).
PMID: 36986049
PMC: 10051692.
DOI: 10.3390/nu15061319.
Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy.
Ashrafizadeh M, Hushmandi K, Mirzaei S, Bokaie S, Bigham A, Makvandi P
Bioeng Transl Med. 2023; 8(1):e10325.
PMID: 36684100
PMC: 9842052.
DOI: 10.1002/btm2.10325.
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers.
Li Y, Zhao J, Xue Z, Tsang C, Qiao X, Dong L
Front Cell Dev Biol. 2022; 10:1053984.
PMID: 36544906
PMC: 9760908.
DOI: 10.3389/fcell.2022.1053984.
Metal-Polymer Nanoconjugates Application in Cancer Imaging and Therapy.
Figueiredo A, Rodrigues C, Fernandes N, de Melo-Diogo D, Correia I, Moreira A
Nanomaterials (Basel). 2022; 12(18).
PMID: 36144953
PMC: 9503975.
DOI: 10.3390/nano12183166.
Aptamer-Based Tumor-Targeted Diagnosis and Drug Delivery.
Woldekidan H, Woldesemayat A, Adam G, Tafesse M, Thimiri Govinda Raj D
Adv Exp Med Biol. 2022; 1409:173-192.
PMID: 35896892
DOI: 10.1007/5584_2022_732.
Applications of Smartphone-Based Aptasensor for Diverse Targets Detection.
Lan Y, He B, Tan C, Ming D
Biosensors (Basel). 2022; 12(7).
PMID: 35884280
PMC: 9312806.
DOI: 10.3390/bios12070477.
Monoclonal Antibody Functionalized, and L-lysine α-Oxidase Loaded PEGylated-Chitosan Nanoparticle for HER2/Neu Targeted Breast Cancer Therapy.
Saravanakumar K, Sathiyaseelan A, Park S, Kim S, Priya V, Wang M
Pharmaceutics. 2022; 14(5).
PMID: 35631513
PMC: 9146122.
DOI: 10.3390/pharmaceutics14050927.
Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy.
Foglizzo V, Marchio S
Cancers (Basel). 2022; 14(10).
PMID: 35626078
PMC: 9139219.
DOI: 10.3390/cancers14102473.
Multivalent Aptamer Approach: Designs, Strategies, and Applications.
Wang Z, Yang X, Lee N, Cao X
Micromachines (Basel). 2022; 13(3).
PMID: 35334728
PMC: 8956053.
DOI: 10.3390/mi13030436.
Chitosan as an Underrated Polymer in Modern Tissue Engineering.
Kolodziejska M, Jankowska K, Klak M, Wszola M
Nanomaterials (Basel). 2021; 11(11).
PMID: 34835782
PMC: 8625597.
DOI: 10.3390/nano11113019.
Synthesis and Characterization of 2-Decenoic Acid Modified Chitosan for Infection Prevention and Tissue Engineering.
Wells C, Coleman E, Yeasmin R, Harrison Z, Kurakula M, Baker D
Mar Drugs. 2021; 19(10).
PMID: 34677455
PMC: 8538315.
DOI: 10.3390/md19100556.